Regulatory
KinetoChem possesses three U.S. Drug Enforcement Administration (DEA) licenses for Schedule 1 controlled substances:
KinetoChem develops processes and procedures to meet FDA and cGMP guidelines.
We have expertise in small molecule synthesis and large-scale liquid chromatography to provide high purity compounds.
KinetoChem’s services provide the ability to move API products from inception to full cGMP manufacturing.
![](https://kinetochem.com/wp-content/uploads/2020/02/328ff3_dc9d4c06224d478db1e5d8350099cb19_mv2.png)